Guoyu Wang

Seventh People's Hospital Of Shanghai University Of Traditional Chinese Medicine 358 Datong Road
Pudong, 200137, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis.

Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis.

Journal: Technology and health care : official journal of the European Society for Engineering and Medicine

Published: September 13, 2024

lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.

lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.

Journal: Cellular and molecular life sciences : CMLS

Published: October 10, 2022

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

Journal: Experimental and therapeutic medicine

Published: July 15, 2022

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.

Journal: Oncology letters

Published: June 20, 2022

Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery.

Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery.

Journal: Cellular & molecular biology letters

Published: June 16, 2022

Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review.

Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review.

Journal: Frontiers in cell and developmental biology

Published: July 29, 2020

RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1.

RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1.

Journal: American journal of cancer research

Published: July 26, 2020

PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.

PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.

Journal: Molecular medicine reports

Published: July 13, 2020

GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway.

GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway.

Journal: Molecular medicine reports

Published: November 12, 2019

GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway.

GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway.

Journal: Journal of Cancer

Published: July 13, 2019

MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion.

MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion.

Journal: OncoTargets and therapy

Published: December 22, 2018

MicroRNA‑373 exerts anti‑tumor functions in human liver cancer by targeting Rab22a.

MicroRNA‑373 exerts anti‑tumor functions in human liver cancer by targeting Rab22a.

Journal: Molecular medicine reports

Published: June 05, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026